These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3997244)

  • 1. Complement activation and attack on autologous cell membranes induced by streptolysin-O.
    Bhakdi S; Tranum-Jensen J
    Infect Immun; 1985 Jun; 48(3):713-9. PubMed ID: 3997244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane damage by channel-forming proteins: staphylococcal alpha-toxin, streptolysin-O and the C5b-9 complement complex.
    Bhakdi S; Tranum-Jensen J
    Biochem Soc Symp; 1985; 50():221-33. PubMed ID: 2428369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins.
    Bhakdi S; Bayley H; Valeva A; Walev I; Walker B; Kehoe M; Palmer M
    Arch Microbiol; 1996 Feb; 165(2):73-9. PubMed ID: 8593102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of membrane damage by streptolysin-O.
    Bhakdi S; Tranum-Jensen J; Sziegoleit A
    Infect Immun; 1985 Jan; 47(1):52-60. PubMed ID: 3880730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of complement cytolysis and the concept of channel-forming proteins.
    Bhakdi S; Tranum-Jensen J
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):311-24. PubMed ID: 6149576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O.
    Hugo F; Reichwein J; Arvand M; Krämer S; Bhakdi S
    Infect Immun; 1986 Dec; 54(3):641-5. PubMed ID: 3781620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of protein channels in target membranes.
    Bhakdi S; Tranum-Jensen J
    Adv Exp Med Biol; 1985; 184():3-21. PubMed ID: 3898753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum complement activation pathways and circulating anti-streptolysin-0 antibodies: diagnostic value in glomerulonephritis in children].
    Rabhi H; Ghaffor M; Salah-Salah H; Abbadi MC
    Arch Inst Pasteur Alger; 1986; 55():99-105. PubMed ID: 2978952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanism of membrane pore formation with cholesterol binding cytolysin: streptolysin O and perfringolysin O].
    Shimizu T; Hayashi H
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):532-9. PubMed ID: 11268657
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poration by alpha-toxin and streptolysin O: an approach to analyze intracellular processes.
    Ahnert-Hilger G; Mach W; Föhr KJ; Gratzl M
    Methods Cell Biol; 1989; 31():63-90. PubMed ID: 2779453
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of C-reactive protein, streptolysin O, and anti-streptolysin O antibodies in immune complexes isolated from the sera of patients with acute rheumatic fever.
    Gupta RC; Badhwar AK; Bisno AL; Berrios X
    J Immunol; 1986 Oct; 137(7):2173-9. PubMed ID: 3489756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of two hemolytic forms of streptolysin-O.
    Bhakdi S; Roth M; Sziegoleit A; Tranum-Jensen J
    Infect Immun; 1984 Nov; 46(2):394-400. PubMed ID: 6500696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Parameters Beyond Lipid Binding Affinity Drive Cytotoxicity of Cholesterol-Dependent Cytolysins.
    Ray S; Thapa R; Keyel PA
    Toxins (Basel); 2018 Dec; 11(1):. PubMed ID: 30577571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of streptolysin-O with natural and artificial membranes.
    Fehrenbach FJ; Eibl H
    Z Naturforsch C Biosci; 1977; 32(1-2):101-9. PubMed ID: 139770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes.
    Parrisius J; Bhakdi S; Roth M; Tranum-Jensen J; Goebel W; Seeliger HP
    Infect Immun; 1986 Jan; 51(1):314-9. PubMed ID: 3079734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-dependent cytolysins.
    Gilbert RJ
    Adv Exp Med Biol; 2010; 677():56-66. PubMed ID: 20687480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approximate dimensions of membrane lesions produced by streptolysin S and streptolysin O.
    Buckingham L; Duncan JL
    Biochim Biophys Acta; 1983 Mar; 729(1):115-22. PubMed ID: 6299345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.